Literature DB >> 23640233

Diffuse FDG uptake due to fat necrosis following transverse rectus abdominus myocutaneous (TRAM) flap reconstruction.

Nathan B Dobbs1, Hamid R Latifi.   

Abstract

We report a case of a 57-year-old female patient with right breast invasive ductal carcinoma. Bilateral mastectomy and TRAM flap reconstructions were performed. Postoperatively, a palpable focus was identified within the left breast. PET/CT showed hypermetabolism throughout the reconstructed left breast, correlating with mixed fat attenuation and inflammatory soft tissue. MRI showed extensive fat necrosis/oil cyst formation in the left breast. As a TRAM flap reconstruction with fat-rich tissue can be damaged intraoperatively due to surgical manipulation, abnormal FDG uptake in this setting is more likely related to fat necrosis than recurrent tumor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640233     DOI: 10.1097/RLU.0b013e31828e9948

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Fat necrosis after abdominal surgery: A pitfall in interpretation of FDG-PET/CT.

Authors:  Tima Davidson; Eyal Lotan; Eyal Klang; Johnatan Nissan; Jeffrey Goldstein; Elinor Goshen; Simona Ben-Haim; Sara Apter; Bar Chikman
Journal:  Eur Radiol       Date:  2017-12-20       Impact factor: 5.315

Review 2.  Fat Necrosis of the Breast: A Pictorial Review of the Mammographic, Ultrasound, CT, and MRI Findings with Histopathologic Correlation.

Authors:  William D Kerridge; Oleksandr N Kryvenko; Afua Thompson; Biren A Shah
Journal:  Radiol Res Pract       Date:  2015-03-16

3.  Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT.

Authors:  Aisheng Dong; Yang Wang; Jianping Lu; Changjing Zuo
Journal:  Clin Nucl Med       Date:  2016-07       Impact factor: 7.794

4.  Drug injection-related fat necrosis of the breast with FDG PET-CT uptake.

Authors:  Lauren Kay Toney; Diana L Lam; Habib Rahbar
Journal:  Radiol Case Rep       Date:  2015-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.